Crompton Greaves
Crompton Greaves
Consumer Goods F&OKey Fundamentals
MicrocapHousehold AppliancesConsumer GoodsTapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
2- Company has reduced debt.
- Company is almost debt free.
Weaknesses
2- The company has delivered a poor sales growth of 8.65% over past five years.
- Debtor days have increased from 38.8 to 51.5 days.
Growth Rate
AI Analysis — Bull vs Bear
Crompton Greaves Consumer Electricals has a market cap of about ₹14,167 crore, trades at 4.78x book value and is almost debt free. Sales have grown at a steady 7% (TTM and 3-year), but profit has fallen 14% TTM and 9% a year over 3 years, and ROE has dropped from a 10-year average of 23% to 10% last year. The stock has returned -25% over 1 year and -14% a year over 5 years. The dataset shows a negative P/E of -66.9, which conflicts with a positive 10% ROE and should be checked against the company's filings.
- The balance sheet is almost debt free and debt has been reduced, which gives the company room to handle a slowdown in earnings and to fund capex or brand spending without much interest cost.
- Over the long run, the company has shown strong capital efficiency: 10-year average ROE is 23% and 5-year average is 17%, above the most recent 10%.
- Sales have compounded at 15% a year over 10 years and profit at 12% a year, showing the franchise has grown well across cycles.
- Revenue growth has been steady rather than falling: TTM sales growth of 7% matches the 3-year CAGR of 7%, which suggests stable demand despite margin pressure.
- The share price has fallen sharply: -25% over 1 year, -10% a year over 3 years and -14% a year over 5 years. Valuation now reflects much lower expectations than in earlier years.
- A dividend yield of 1.36% gives some cash return to shareholders even while earnings are weak.
- ROE is still positive at 10% last year, so the company remains profitable at the return-on-equity level even as earnings shrink.
- Profit has fallen on every recent timeframe: -14% TTM, -9% a year over 3 years and -10% a year over 5 years. This points to ongoing margin or cost pressure rather than a one-off dip.
- ROE has dropped from a 10-year average of 23% to 17% (5-year), 14% (3-year) and 10% last year, a steady fall in return on capital.
- Sales growth has slowed a lot. The 5-year sales CAGR is about 8.65–9%, versus 15% over 10 years.
- Debtor days have risen from 38.8 to 51.5, which suggests looser credit terms to distributors or weaker collections, and it ties up working capital.
- A P/B of 4.78 alongside a 10% ROE implies a high multiple relative to current returns. The valuation depends on returns recovering toward historical levels.
- The stock has lost value over long periods, with -14% a year over 5 years and -10% a year over 3 years, well below the 4% a year over 10 years.
- The reported P/E of -66.9 indicates negative trailing earnings in the dataset, which is inconsistent with the 10% ROE last year. Earnings quality or one-off charges should be checked against filings.
- The 1.36% dividend yield is modest and gives limited downside cushion if profits keep falling at the recent 9–14% annual rate.
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
- FY18 GST interest demand upheld Sep 11
The Deputy Commissioner of Appeals, Chennai, upheld a GST interest demand of ₹8,37,680 for FY18. Crompton plans to appeal, and the amount is financially immaterial.
- WallSmile outdoor lights launched Sep 12
Crompton launched the WallSmile Outdoor Deco Wall Light range: four models priced at ₹1,000–2,000 with IP54 water resistance and surge protection. This extends its premium decorative lighting portfolio.
- Singapore NDR on Sep 28-29 Sep 23
Crompton will hold a Non-Deal Roadshow in Singapore on September 28-29, 2026, with one-to-one meetings with institutional investors. This points to ongoing outreach to foreign investors.
- Domestic MF meetings: UTI, Invesco, Bandhan Sep 22
Physical one-to-one meetings with Invesco MF and Bandhan MF are set for September 15, 2026, and a meeting with UTI MF for September 30, 2026. No price-sensitive information is expected.
- Foreign fund one-to-ones in September Sep 11
One-to-one meetings with East Bridge Capital (Sep 9), Amansa Capital (Sep 11), Eternal Capital (Sep 16, virtual) and Schonfeld Strategic Advisors (Sep 17, 12:00–1:00 pm, virtual).
- Elara India Dialogue on Sep 3 Aug 31
A physical meeting with analysts and institutional investors on September 3, 2026, held as part of the Ashwamedh – Elara India Dialogue 2026.
- Revised investor presentation filed Aug 31
Crompton filed a revised investor presentation to fix clerical errors. Financial data and strategic conclusions did not change.
TL;DR: The news flow for Crompton is mostly routine. It is dominated by an intensive September investor-engagement calendar with more than 9 institutional meetings plus a Singapore NDR, which signals active courting of domestic and foreign funds. The only fundamental positive is the WallSmile lighting launch. The one risk item, a ₹8.37 lakh FY18 GST interest demand, is immaterial and under appeal. With no material operational news, the trend is stable rather than clearly improving, and the next real catalysts are likely to be festive-season demand and the upcoming quarterly results.
Quarterly Results
| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,657 | 1,476 | 1,458 | 1,797 | 1,959 | 1,645 | 1,545 | 1,878 | 1,819 | 1,632 | 1,659 | 2,083 | 2,022 |
| Expenses | 1,492 | 1,326 | 1,311 | 1,571 | 1,737 | 1,465 | 1,374 | 1,630 | 1,641 | 1,502 | 1,485 | 1,830 | 1,814 |
| Operating Profit | 166 | 151 | 147 | 225 | 222 | 180 | 171 | 248 | 178 | 130 | 174 | 253 | 208 |
| OPM % | 10% | 10% | 10% | 13% | 11% | 11% | 11% | 13% | 10% | 8% | 10% | 12% | 10% |
| Other Income | 19 | 12 | 15 | 14 | 22 | 16 | 10 | 16 | 22 | -4 | -8 | -703 | 19 |
| Interest | 19 | 20 | 20 | 14 | 14 | 10 | 9 | 12 | 9 | 5 | 8 | 9 | 10 |
| Depreciation | 14 | 16 | 17 | 19 | 20 | 21 | 21 | 23 | 23 | 27 | 26 | 27 | 29 |
| PBT | 151 | 128 | 126 | 206 | 211 | 165 | 151 | 229 | 168 | 94 | 132 | -485 | 189 |
| Tax % | 24% | 26% | 24% | 22% | 25% | 25% | 26% | 26% | 25% | 25% | 26% | 11% | 26% |
| Net Profit | 115 | 95 | 95 | 161 | 158 | 123 | 112 | 171 | 125 | 70 | 98 | -537 | 140 |
| EPS in Rs | 1.8 | 1.48 | 1.49 | 2.5 | 2.45 | 1.92 | 1.74 | 2.65 | 1.94 | 1.09 | 1.53 | -8.34 | 2.18 |
Profit & Loss
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 1,783 | 3,901 | 4,080 | 4,479 | 4,512 | 4,750 | 5,373 | 5,809 | 6,388 | 7,028 | 7,193 | 7,397 |
| Expenses | 3 | 1,574 | 3,416 | 3,549 | 3,893 | 3,915 | 4,045 | 4,612 | 5,138 | 5,700 | 6,197 | 6,447 | 6,632 |
| Operating Profit | -3 | 209 | 485 | 531 | 586 | 597 | 705 | 761 | 671 | 689 | 831 | 746 | 765 |
| OPM % | — | 12% | 12% | 13% | 13% | 13% | 15% | 14% | 12% | 11% | 12% | 10% | 10% |
| Other Income | 0 | -10 | 17 | 31 | 48 | 59 | 76 | 80 | 80 | 60 | 64 | -692 | -695 |
| Interest | 0 | 35 | 66 | 64 | 60 | 41 | 43 | 35 | 103 | 73 | 55 | 42 | 31 |
| Depreciation | 0 | 6 | 11 | 13 | 13 | 27 | 30 | 42 | 54 | 65 | 84 | 102 | 108 |
| PBT | -3 | 158 | 425 | 485 | 562 | 588 | 708 | 763 | 594 | 611 | 756 | -91 | -70 |
| Tax % | -35% | 33% | 33% | 33% | 28% | 16% | 15% | 22% | 20% | 24% | 25% | 168% | — |
| Net Profit | -2 | 105 | 283 | 324 | 403 | 495 | 605 | 593 | 476 | 466 | 563 | -243 | -228 |
| EPS in Rs | -74.8 | 1.68 | 4.52 | 5.17 | 6.42 | 7.89 | 9.63 | 9.37 | 7.48 | 7.25 | 8.75 | -3.78 | -3.54 |
| Div. Payout % | 0% | 0% | 33% | 34% | 31% | 0% | 57% | 27% | 40% | 41% | 34% | -79% | — |
Balance Sheet
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.05 | 125 | 125 | 125 | 125 | 125 | 126 | 127 | 127 | 129 | 129 | 129 |
| Reserves | -2 | 103 | 392 | 664 | 973 | 1,342 | 1,793 | 2,329 | 2,712 | 3,077 | 3,475 | 3,049 |
| Borrowings | 0 | 644 | 648 | 649 | 649 | 350 | 518 | 1,632 | 1,000 | 679 | 466 | 192 |
| Other Liabilities | 3 | 780 | 948 | 987 | 922 | 927 | 1,107 | 1,238 | 1,307 | 1,690 | 1,881 | 2,273 |
| Total Liabilities | 1 | 1,653 | 2,113 | 2,425 | 2,670 | 2,744 | 3,544 | 5,326 | 5,146 | 5,574 | 5,952 | 5,642 |
| Fixed Assets | 0 | 858 | 862 | 862 | 863 | 909 | 915 | 1,099 | 1,122 | 1,120 | 1,270 | 1,263 |
| CWIP | 0 | 0 | 0 | 1 | 1 | 20 | 11 | 8 | 24 | 51 | 23 | 27 |
| Investments | 0 | 0 | 319 | 368 | 544 | 554 | 775 | 2,018 | 2,459 | 2,556 | 2,546 | 2,073 |
| Other Assets | 1 | 795 | 933 | 1,195 | 1,261 | 1,261 | 1,843 | 2,202 | 1,541 | 1,847 | 2,113 | 2,280 |
| Total Assets | 1 | 1,653 | 2,113 | 2,425 | 2,670 | 2,744 | 3,544 | 5,326 | 5,146 | 5,574 | 5,952 | 5,642 |
Cash Flow
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 0 | 176 | 313 | 315 | 301 | 421 | 815 | 730 | 425 | 796 | 716 | 637 |
| Investing | 0 | 2 | -319 | -33 | -171 | -2 | -489 | -1,720 | 299 | -176 | -87 | -100 |
| Financing | 0 | -88 | -17 | -175 | -186 | -513 | -96 | 907 | -850 | -534 | -566 | -591 |
| Net Cash Flow | 0 | 90 | -24 | 107 | -56 | -93 | 230 | -83 | -126 | 87 | 63 | -54 |
| Free Cash Flow | 0 | 174 | 298 | 302 | 286 | 373 | 795 | 560 | 360 | 734 | 623 | 570 |
| CFO/OP | 0 | 110 | 95 | 94 | 85 | 95 | 123 | 118 | 81 | 128 | 107 | 104 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | — | 85 | 44 | 50 | 46 | 37 | 35 | 33 | 33 | 33 | 32 | 52 |
| Inventory Days | — | 60 | 36 | 40 | 42 | 55 | 58 | 51 | 56 | 58 | 59 | 44 |
| Days Payable | — | 191 | 95 | 100 | 78 | 76 | 89 | 84 | 81 | 97 | 102 | 129 |
| Cash Conversion Cycle | — | -45 | -14 | -11 | 9 | 16 | 4 | 0 | 8 | -6 | -10 | -33 |
| Working Capital Days | — | -45 | -11 | -2 | -14 | 5 | -3 | -107 | -13 | -20 | -22 | -11 |
| ROCE % | — | 48% | 48% | 42% | 38% | 35% | 34% | 24% | 17% | 18% | 20% | 19% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Crompton Greaves insights
65 extracted metrics + investor summaries across FY15–FY27.
Documents
Frequently Asked Questions about Crompton Greaves
What does Crompton Greaves Consumer Electricals Ltd do?
Where is Crompton Greaves Consumer Electricals Ltd (CROMPTON) listed?
Which sector does Crompton Greaves Consumer Electricals Ltd belong to?
What is the market capitalisation of Crompton Greaves Consumer Electricals Ltd?
What is the PE ratio of Crompton Greaves Consumer Electricals Ltd?
What is the 52-week high and low of Crompton Greaves Consumer Electricals Ltd?
Does Crompton Greaves Consumer Electricals Ltd pay dividends?
What is the Return on Equity (ROE) of Crompton Greaves Consumer Electricals Ltd?
Company Information
Crompton Greaves Consumer Electricals Limited is one of the leading consumer companies in India with a 75+ years old brand legacy. It is an independent company under professional management and have 2 business segments – Lighting and Electrical Consumer Durables. We market our products under the “Crompton” brand name in India and select export markets. [1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/CROMPTON.md for Crompton Greaves Consumer Electricals Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.